Search Within

Solid Tumor Oncology Division

Formats
  1. Journal Article (11004)
  2. Meeting Abstract (9530)
  3. Review (575)
  4. Book Section (417)
  5. Editorial (341)
  6. Guidelines (161)
  7. Correspondence (120)
  8. Conference Paper (107)
  9. Research Letter (63)
  10. Miscellaneous (55)
  11. Book Whole (27)
Groups
  1. Department of Medicine (22376)
  2. GSK Faculty (5953)
  3. Genitourinary Oncology Service (5684)
  4. Survivorship Research (5261)
  5. Gastrointestinal Oncology Service (4738)
  6. Breast Medicine Service (4179)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. Clifford Hudis (906)
  4. Jedd Wolchok (905)
  5. Mark Kris (873)
  6. Eileen O'Reilly (800)

More People

Years
  1. 2025 (776)
  2. 2024 (1389)
  3. 2023 (1381)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1536)

More Years

Publications
  1. Journal of Clinical Oncology (5297)
  2. Annals of Oncology (1309)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (781)
  5. Journal of Thoracic Oncology (534)
  6. Gynecologic Oncology (443)

More Publications

Publishers
  1. American Society of Clinical Oncology (5592)
  2. American Association for Cancer Research (2332)
  3. Elsevier Inc. (2239)
  4. Oxford University Press (1838)
  5. Nature Publishing Group (1053)
  6. Springer (992)

More Publishers

Results (22400)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial
    Journal Article

    Ledermann, J. A.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
    European Journal of Cancer (2025)

    Fulltext@MSK | Save
  • A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma
    Journal Article

    Rosenbaum, E.; Seier, K.; Bradic, M.; Movva, S.; Kelly, C. M.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Nacev, B. A.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • Consensus guidance for prevention and management of nausea and vomiting in patients treated with zolbetuximab + chemotherapy: A RAND/UCLA modified Delphi panel study
    Journal Article

    Klempner, S. J.; Pazo-Cid, R. A.; Lonardi, S.; Swanson, L.; Arango, M. J.; Enzinger, P.; Ko, A. H.; Vaccaro, G. M.; Yamaguchi, K.; Saeed, A.; more...
    ESMO Gastrointestinal Oncology (2025)

    Fulltext@MSK | Save
  • Clinicopathologic features, molecular landscape, and prognostic implications of ovarian low-grade serous tumors with histologic transformation
    Journal Article

    Chui, M. H.; Kang, E. Y.; Kahn, R. M.; Chiang, S.; Zhou, Q.; Iasonos, A.; Manning-Geist, B.; Selenica, P.; Da Cruz Paula, A.; Long Roche, K.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • First-in-human phase I/IIa study of the first-in-class CDK2/4/6 inhibitor PF-06873600 alone or with endocrine therapy in patients with breast cancer
    Journal Article

    Yap, T. A.; Goldman, J. W.; Vinayak, S.; Tomova, A.; Hamilton, E.; Naito, Y.; Giordano, A.; Bondarenko, I.; Yamashita, T.; Zhou, L.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • ctDNA analysis in ERBB2-amplified colorectal cancer: Biomarker analysis of the MyPathway trial
    Journal Article

    Meric-Bernstam, F.; Raghav, K. P. S.; Sweeney, C. J.; Swanton, C.; Spigel, D. R.; Bose, R.; Burris, H. A.; Friedman, C. F.; Espenschied, C. R.; Grindheim, J. M.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Liquid and tissue biopsies for identifying MET exon 14 skipping NSCLC: Analyses from the phase II VISION study of tepotinib
    Journal Article

    Rolfo, C.; O’Brate, A.; Menzel, C.; Bruns, R.; Juraeva, D.; Stroh, C.; Johne, A.; Paik, P. K.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Integration of next generation sequencing data to inform survival prediction of patients with spine metastasis
    Journal Article

    Giantini-Larsen, A.; Ramos, A. D.; Martin, A.; Panageas, K. S.; Kostrzewa, C. E.; Abou-Mrad, Z.; Schmitt, A.; Bromberg, J. F.; Safonov, A.; Rudin, C. M.; more...
    Cancers (2025)

    Fulltext@MSK | Save
  • Direct inhibition of RAS reveals the features of oncogenic signaling driven by RAS G12 and Q61 mutations
    Journal Article

    Marasco, M.; Kumar, D.; Garcia Borrego, S.; Seale, T.; Maddalena, G.; Mezzadra, R.; Belanger, K.; Cole, S.; Perez, B.; Luan, W.; more...
    Cancer Discovery (2025)

    Fulltext@MSK | Save
  • Patient characteristics associated with conventional schedule vs. dose dense chemotherapy in women with stage I–IIIA breast cancer
    Journal Article

    Bhimani, J.; Wang, P.; Gallagher, G. B.; O’Connell, K.; Persaud, S.; Blinder, V. S.; Burganowski, R.; Ergas, I. J.; Griggs, J. J.; Heon, N.; more...
    Breast Cancer Research and Treatment (2025)

    Fulltext@MSK | Save